ACTH alpha (1-18) is an N-terminal peptide containing aromatic and charged residues central to structural transitions in ACTH-derived sequences. Its amphipathic profile supports receptor-interaction studies. The sequence enables mapping of early motif determinants. Researchers apply it in biochemical analysis of melanocortin peptides.
CAT No: A03053
CAS No:1285-85-4
Synonyms/Alias:ACTH alpha (1-18);alpha 1-18 Acth;ACTH alpha(1-18);1-18 Acth;Acth a(1-18);1285-85-4;alpha1-18-Corticotropin;DTXSID10155914;DTXCID0078405;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.